Clinical and Epidemiological Metabonomics

نویسندگان

  • Mika Ala-Korpela
  • Veikko Salomaa
  • Olav M. Kvalheim
چکیده

1College of Chemistry and Chemical Engineering, Central South University, Changsha 410083, Hunan Province, China 2Computational Medicine Research Group, Institute of Clinical Medicine, Faculty of Medicine, University of Oulu and Biocenter Oulu, P.O. Box 5000, 90014 University of Oulu, Oulu, Finland 3NMRMetabonomics Laboratory, Department of Biosciences, University of Eastern Finland, 70211 Kuopio, Finland 4Department of Internal Medicine and Biocenter Oulu, Clinical Research Center, University of Oulu, 90014 University of Oulu, Oulu, Finland 5Chronic Disease Epidemiology and Prevention Unit, Department of Chronic Disease Prevention, The National Institute for Health and Welfare, 00271 Helsinki, Finland 6Department of Chemistry, University of Bergen, 5007 Bergen, Norway 7Faculty of Health Studies, Sogn og Fjordane University College, 6800 Førde, Norway

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Metabolomics in Cardiovascular Disease: Towards Clinical Application

Metabolomics were initially defined as the global analysis of all metabolites present in a sample (metabolomics) and the analysis of metabolic responses to drugs and diseases (metabonomics) [Nicholson et al., 1999, Fiehn 2002, Weckwerth and Morgenthal 2005]. These two definitions have an historical origin, while metabolomics has its foundations in microbial and plant sciences metabonomics origi...

متن کامل

Metabonomics in the preclinical and environmental toxicity field.

Preclinical studies assess both efficacy and safety of new drugs through a series of assays used to identify potential target organs and determine safety thresholds. However, despite these efforts, too many drugs prove toxic to humans during clinical phases or later on the market. This paper reviews how metabonomics, one of the key players in systems biology, should be able to assist toxicologi...

متن کامل

A Novel Bayesian Approach for Uncovering Potential Spectroscopic Counterparts for Clinical Variables in H NMR Metabonomic Applications

Metabonomic approaches based on spectroscopic data are in their infancy in biomedicine. A key challenge in clinical metabonomics is uncovering and understanding the relations between the multidimensional spectroscopic data and the clinical measures currently used for disease risk assessment and diagnostics. A novel Bayesian approach for revealing clinically relevant signals is presented here fo...

متن کامل

Clinical and Epidemiological Features of Early and Adult Onset Multiple Sclerosis in Hamedan, Iran, 2004–2005

Mazaheri Sh1, Fazlian MM2, Hossein Zadeh A3 1. Assistant Professor, Department of Neurology, Faculty of medicine, Hamedan University of Medical Sciences 2. General practitioner, Specialty and Subspecialty Hospital of Besat, Hamedan University of Medical Sciences 3. General practitioner, Hamedan Health Center Abstract Background: Multiple Sclerosis (MS) is one of the most common causes of chr...

متن کامل

UPLC-based metabonomic applications for discovering biomarkers of diseases in clinical chemistry.

OBJECTIVES Metabonomics is a powerful and promising analytic tool that allows assessment of global low-molecular-weight metabolites in biological systems. It has a great potential for identifying useful biomarkers for early diagnosis, prognosis and assessment of therapeutic interventions in clinical practice. The aim of this review is to provide a brief summary of the recent advances in UPLC-ba...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 2011  شماره 

صفحات  -

تاریخ انتشار 2011